Cardiologist: New Study Shows Soft Plaque Melts Away (FLOWPROMOTE)

🚨 A new trial just showed that dangerous soft plaque shrank in 51 out of 52 patients, almost everyone, when treated with rosuvastatin plus ezetimibe.

🔬 Researchers scanned every single coronary artery with CT imaging and plotted the results on a waterfall chart showing plaque regression patient by patient.

🩺 I break down the actual LDL numbers behind this result so you understand what drove the plaque shrinkage.

💡 Here's the twist, a rising calcium score after starting a statin is not actually bad news, and I explain why in this episode.

❤️ Soft plaque is the dangerous, unstable kind that ruptures and causes heart attacks, so shrinking it matters for your heart.

✅ Bottom line: this study shows aggressive LDL lowering with rosuvastatin plus ezetimibe can shrink soft plaque in nearly everyone, so talk to your doctor about your LDL goals and statin therapy.